The deal underlines the investors' commitment and enables the scaleup to continue developing new services
The exit has an initial value of USD 250 million, which may rise to USD 752.5 million, and will be finalised by the second half of 2025
Finnish start-up with offices also in Italy and Australia closes a EUR 19 million round to develop cancer treatments
The digital health SME is on its second collection campaign and is preparing to develop new services
Italian scaleup specialising in logistics solutions reports growing turnover and intends to grow internationally
The start-up has developed a patented technology based on sound waves and acoustic modulation that improves bioproduction
The deal that was announced in November 2024 is worth USD 233m and involves the delisting of the US company
The transaction was carried out by the Swiss subsidiary of the Italian company and involves Simest and Intesa Sanpaolo
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.